Geron

GERN

GERN
Geron Stock Quote
$1.51 -$0.01 -0.7%
BATS BZX Real Time Price as of December 6, 2019, 4:00 p.m. EST View Interactive GERN Charts

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS.

News & Analysis: Geron

The Fool has written over 300 articles on Geron.

All

Market Moves

Podcasts

Earnings











Interactive Chart